A physiological reason may explain why the shrinking violet in your family is so shy. Using brain SPECT, Dutch researchers have detected irregularities in dopamine and serotonin neurotransmitter systems in the brains of such individuals that appear to be linked to social anxiety disorder, a condition that affects an estimated 15 million adults in the U.S. and frequently leads to alcoholism and depression.
A physiological reason may explain why the shrinking violet in your family is so shy. Using brain SPECT, Dutch researchers have detected irregularities in dopamine and serotonin neurotransmitter systems in the brains of such individuals that appear to be linked to social anxiety disorder, a condition that affects an estimated 15 million adults in the U.S. and frequently leads to alcoholism and depression.
Dr. Nic J.A. van der Wee, a psychiatrist specializing in anxiety disorders and psychiatric neuroimaging, and colleagues at Leiden University in the Netherlands used a binding radioactive compound (123I-β-(4-iodophenyl)-tropane) as a tracer to visualize dopamine and serotonin transporters in the brain. The procedure was performed on 12 patients diagnosed with social anxiety disorder who had not taken medication to treat the condition and 12 healthy controls.
In the patients with social anxiety disorder, SPECT revealed altered uptake activity in the thalamus, midbrain, and pons, areas known to be acted upon by serotonin, and in the striatum, an area known to be acted upon by dopamine. The significantly higher binding potentials found in the social anxiety disorder patients indicate imbalances that may affect the way their brains function in normal situations, causing anxiety.
"We found the first direct evidence for abnormalities of the brain's dopaminergic system in patients with social anxiety disorder," said van der Wee. "The study demonstrates that social anxiety has a physical brain-dependent component."
One unique aspect of the research was that it included only patients without prior exposure to pharmacotherapy.
"Our findings broaden the neurobiological model of social anxiety disorder and may lead to novel research not only in pharmacotherapy but also in the etiology of the disorder," van der Wee said.
The study was published in the May issue of the Journal of Nuclear Medicine (2008;49[5]:757-763).
The Netherlands team conducted the research with SPECT, citing that it is easy to use and does not require extensive facilities to produce the radioactive compound. Compared with PET, SPECT offers a higher patient comfort level, lower cost, and higher safety index, according to van der Wee.
Van der Wee and his team are expanding on their research as part of the large-scale Netherlands Depression and Anxiety Study. It is examining 3000 subjects, including patients with social anxiety disorder. The effort will feature a structural and functional brain imaging study using novel MRI techniques in a subset of 300 patients, including patients with society anxiety disorder.
For more information from the Diagnostic Imaging archives:
Brain imaging study uncovers neurophysiology of drunken behavior
Functional MR reveals how brain bops during jazz improv
Functional MRI snoops out how, why we decide to buy
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
2 Commerce Drive
Cranbury, NJ 08512